Paradigm Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,100
| Closed | -$86.8K | – | 526 |
|
|
2017
Q2 | $86.8K | Sell |
1,100
-1,200
| -52% | -$94.7K | 0.02% | 444 |
|
|
2017
Q1 | $191K | Buy |
2,300
+100
| +5% | +$8.29K | 0.04% | 383 |
|
|
2016
Q4 | $175K | Sell |
2,200
-100
| -4% | -$7.93K | 0.03% | 301 |
|
|
2016
Q3 | $161K | Buy |
+2,300
| New | +$161K | 0.03% | 342 |
|
|
2014
Q3 | – | Sell |
-6,300
| Closed | -$90.3K | – | 877 |
|
|
2014
Q2 | $90.3K | Buy |
+6,300
| New | +$90.3K | 0.01% | 615 |
|